Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Session: Management of Respiratory Viruses in Transplant Recipients in the Post-COVID-19 Pandemic Era

417 - Outlook in Clinical Trials in Antivirals for Respiratory Viruses: Lessons Learned Over the Years

Tuesday, October 21, 2025
2:35 PM - 3:00 PM US ET
Location: Thomas B. Murphy Ballroom 4
Disclosure(s):
Roy F. Chemaly, MD/MPH: ADMA Biologics, Inc.: Advisor/Consultant; AiCuris Anti-Infective Cures AG: Advisor/Consultant, Grant/Research Support; Ansun Biopharma Inc.: Advisor/Consultant, Grant/Research Support; Assembly Bioscience: Advisor/Consultant; Astellas Pharma Inc.: Advisor/Consultant; Eurofins-Viracor: Advisor/Consultant, Grant/Research Support, Honoraria; Gilead Biosciences: Advisor/Consultant; Invivyd, Inc.: Advisor/Consultant; Karius Inc.: Advisor/Consultant, Grant/Research Support; Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support, Honoraria; Moderna, Inc.: Advisor/Consultant; Pfizer Pharmaceutc: Advisor/Consultant; Roche/Genentech: Grant/Research Support; SHIONOGI and CO., LTD.: Advisor/Consultant; Takeda Pharmaceutical: Advisor/Consultant, Grant/Research Support; Tether: Advisor/Consultant